A new startup incubator has just opened in Manhattan this morning, adding to a growing list of facilities meant to help support seedling New York City biotechs. LaunchLabs, first announced by Alexandria Real Estate Equities a year ago, officially opened its doors and revealed the 13 startups that will grow there. LaunchLabs is a 15,000-square-foot […]
NYS Entity Status
NYS Filing Date
FEBRUARY 03, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC PROFESSIONAL SERVICE LIMITED LIABILITY COMPANY
2014 - GOLDBERG & YADEGAR PRIVATE MEDICAL, PLLC
Around the Web
- Alexandria Debuts NY’s Latest Bio Incubator With 13 Startups in Tow
By Ben Fidler - Tuesday Jun 13, 2017
- “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
By Ben Fidler - Wednesday Jun 7, 2017
Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]
- Disrupting the World of Private School With Tech and Guinea Pigs
By KATE TAYLOR - Monday Nov 20, 2017
Start-ups, including one from sharing-economy company WeWork, try to shake up the staid, and pricey, status quo of New York’s independent schools.
- Medical examiner accused of trading prescription drugs for sex
By Joshua Rhett Miller - Wednesday Oct 18, 2017
A veteran medical examiner in Georgia allegedly distributed opioids illegally and traded prescriptions for sex, federal authorities said. Joseph Burton, who runs a private forensic pathology practice in Alpharetta, previously served as the chief medical examiner in DeKalb County and worked as a senior consulting pathologist in Cobb, Gwinnett and Paulding counties. Federal authorities arrested...
- Traces of Crime: How New York’s DNA Techniques Became Tainted
By LAUREN KIRCHNER - Monday Sep 4, 2017
The city’s medical examiner has been a pioneer in analyzing complex DNA samples. But two methods were recently discontinued, raising questions about thousands of cases.